Assessing Early Efficacy After Initiation of Once-Nightly Sodium Oxybate (ON-SXB; FT218) in Participants with Narcolepsy Type 1 or 2: A Post Hoc Analysis from the Phase 3 REST-ON Trial. [PDF]
Krahn L +4 more
europepmc +1 more source
0610 Pharmacokinetics And Dose Proportionality Of FT218, An Investigational Controlled Release Formulation Of Sodium Oxybate For Once Nightly Dosing [PDF]
David Monteith +3 more
openaire +1 more source
Optimizing patient outcomes and empowering the patient-clinician partnership. [PDF]
Thorpy M.
europepmc +1 more source
Sleep-related eating disorder after dose escalation of sodium oxybate in narcolepsy type 1. [PDF]
Al Mazyad RA +3 more
europepmc +1 more source
Recent Advances and Emerging Pharmacotherapeutic Approaches for Central Hypersomnolence Disorders. [PDF]
Aribindi K, Shende TC, Albertson TE.
europepmc +1 more source
Effectiveness and Safety of Low-Sodium Oxybate in Participants with Idiopathic Hypersomnia: Primary Results from the DUET Study. [PDF]
Plante DT +10 more
europepmc +1 more source
Effectiveness and Safety of Low-Sodium Oxybate in Participants with Narcolepsy: Primary Results from the DUET Study. [PDF]
Schneider LD +10 more
europepmc +1 more source
A historical overview of the cardiovascular safety of sodium oxybate: clinical trials, clinical experience. [PDF]
Kushida CA.
europepmc +1 more source
Narcolepsy as an immune-associated hypothalamic encephalopathy: orexin dysfunction and implications for precision sleep medicine. [PDF]
Arias-Carrión O +3 more
europepmc +1 more source

